Amir A. Zeki, M.D.
Pulmonary and Critical Care
- Assistant Professor -Division of Pulmonary, Critical Care and Sleep Medicine
M.D., University of Washington, Seattle, Washington, 2001
M.A.S., UC Davis, Davis, California, 2009
B.S., University of Washington, Seattle, Washington, 1997
University of California, Davis Medical Center, Sacramento , CA, 2001-04
University of California, Davis Medical Center, Sacramento, CA, 2004-05
University of California, Davis Medical Center, Sacramento, CA, 2005-08
Honors and Awards
Nominated and selected to be President/Chair Elect for the Western Regional American Federation for Medical Research (AFMR)., 2012
Nominated as a CTSC K12 Scholar to become an Associate Scientific Advisor for the journal Science Translational Medicine. In January 2012, Dr. Zeki was selected to be one of eighteen Associate Scientific Advisors. Responsibilities include writing Editor’s Choice articles and manuscript review., 2011
Western Society for Clinical Investigation (WSCI) Travel Award. Western Regional AFMR Meeting. Carmel, CA., 2011
NIH-Loan Repayment Program (LRP) Grant/Award., 2010
U.C. Davis Richard C. Woodard Memorial Endowed Fund Award. Received for outstanding research paper published in the 2009-2010 year (among U.C. Davis investigators)., 2010
K12 Award: U.C. Davis Clinical Translational Science Center (CTSC) Mentored Multidisciplinary Clinical/Translational Research Fellowship/Grant., 2010
American Thoracic Society (ATS) Fellow Career Development Award., 2009
University of Manitoba, Winnipeg. First Prize Award (April 29, 2009) – Poster/Abstract. The Manitoba Research Day 2009., 2009
Central Society for Clinical Research (CSCR) K-award Grant, 2009
Select Recent Publications
Jennifer M. Bratt, Amir A. Zeki, Jerold Last, Nicholas Kenyon. Competitive Metabolism of L-Arginine: Arginase as a Therapeutic Target in Asthma. The Journal of Biomedical Research. 2011. 25(5):299-308.
Olga Fortenko, Amir Zeki, Gertrud Schuster, Cristina Davis, Hooman Allayee, Charles Stephensen, Nicholas Kenyon. Asthma Patients with Specific Genotypes Identified for Fish Oil Treatment Trial. California Agriculture. 2011. 65(3):112-117.
Zeki AA, Kenyon NJ, Goldkorn T. Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research. Drug Metab Lett. 2011 Jan;5(1):40-4. Review.
Zeki AA, Kenyon NJ, Yoneda K, Louie S. The Adult Asthmatic. Clin Rev Allergy Immunol. 2011 Mar 22. [Epub ahead of print]
Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly. J Allergy (Cairo). 2011;2011:861926. Epub 2011 Oct 30.
Zeki AA, Schivo M, Chan AL, Hardin KA, Kenyon NJ, Albertson TE, Rosenquist GL, Louie S. Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun. 2010 May;34(3):J327-38. Epub 2009 Dec 16. Review.
Zeki AA, Bratt JM, Rabowsky M, Last JA, Kenyon NJ. Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling? Transl Res. 2010 Dec;156(6):335-49.
Hekmat Nasiri, Amir A. Zeki, Timothy Albertson. A rare diagnosis: Endobronchial schwannoma. The Journal of Respiratory Diseases. January 4, 2010.
Zeki AA, Franzi L, Last J, Kenyon NJ. Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. Am J Respir Crit Care Med. 2009 Oct 15;180(8):731-40. Epub 2009 Jul 16.
Amir A. Zeki, Nicholas J. Kenyon, Samuel Louie. The NAEPP-EPR3 Asthma Guidelines: A Practical Perspective. The Journal of Respiratory Diseases. 2008. 29(12):481-487.